CollPlant Biotechnologies Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CLGN Nasdaq 2836 collplant.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CollPlant Biotechnologies Ltd.

COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - May 29th, 2026 5:00 am
CollPlant Issues Letter to Shareholders - Apr 13th, 2026 5:00 am
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Mar 26th, 2026 6:30 am
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - Mar 24th, 2026 2:01 pm
CollPlant Biotechnologies Launches Redesigned Corporate Website - Mar 18th, 2026 7:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS - Mar 11th, 2026 6:00 am
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - Feb 26th, 2026 6:00 am
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - Feb 23rd, 2026 5:00 am
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - Feb 17th, 2026 5:00 am
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit? - Feb 8th, 2026 5:45 am
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering - Feb 6th, 2026 6:06 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING - Feb 5th, 2026 6:00 am
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Nov 26th, 2025 5:30 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS - Nov 18th, 2025 5:00 am
Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - Nov 13th, 2025 3:13 am
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada - Oct 27th, 2025 5:00 am
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology - Oct 20th, 2025 5:00 am
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk - Oct 16th, 2025 5:00 am
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year - Oct 3rd, 2025 4:47 am
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - Sep 30th, 2025 5:00 am